Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

OBJECTIVES: To evaluate the potential of immunosuppressed patients to mount B-cell and T-cell responses to COVID-19 booster vaccination (third vaccination). METHODS: Patients with primary immunodeficiency (PID), immune-mediated inflammatory diseases (IMIDs) on CD20-depleting treatment with rituximab...

Descripción completa

Detalles Bibliográficos
Autores principales: Koehm, Michaela, Klippstein, Maximilian, Dauth, Stephanie, Hallmann, Konstantin, Kohmer, Niko, Burkhardt, Harald, Ciesek, Sandra, Geisslinger, Gerd, Rabenau, Holger F, Behrens, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476126/
https://www.ncbi.nlm.nih.gov/pubmed/37652553
http://dx.doi.org/10.1136/rmdopen-2023-003094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476126/
https://www.ncbi.nlm.nih.gov/pubmed/37652553
http://dx.doi.org/10.1136/rmdopen-2023-003094

Ejemplares similares